Where Salesforce Stands With Analysts
Portfolio Pulse from Benzinga Insights
Salesforce (NYSE:CRM) has received mixed analyst ratings over the past three months, with a total of 25 analysts providing their perspectives. The recent ratings show a shift towards a more bullish outlook, with no changes in ratings in the last 30 days. Analysts have raised their 12-month price targets for CRM, indicating an average target of $326.12, which is a 10.89% increase from the previous average of $294.09. Key analysts from firms like Citigroup, Canaccord Genuity, and JP Morgan have raised their price targets, reflecting optimism about Salesforce's future performance. Despite positive revenue growth, Salesforce's financial indicators such as net margin, ROE, and ROA are below industry standards, suggesting challenges in profitability and asset utilization.
March 21, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Salesforce has seen a positive shift in analyst ratings with an upward revision in price targets, indicating a bullish outlook. However, financial challenges such as lower net margin and ROE compared to industry standards may impact investor sentiment.
The increase in analyst price targets and the overall bullish sentiment suggest a positive short-term impact on CRM's stock price. However, the underlying financial challenges highlighted in the article, such as lower profitability and efficiency metrics compared to industry standards, could temper investor enthusiasm. The balance between positive analyst outlook and financial performance concerns will influence CRM's stock price movement.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100